These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 3015637)
21. A parallel study of enalapril and captopril and 1 year of experience with enalapril treatment in moderate-to-severe essential hypertension. Thind GS; Johnson A; Bhatnagar D; Henkel TW Am Heart J; 1985 Apr; 109(4):852-8. PubMed ID: 2984913 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the free radical scavenging activity of captopril versus enalapril: a three month in vivo study in hypertensive diabetic patients. Bain SC; Le Guen CA; Lunec J; Barnett AH J Hum Hypertens; 1991 Dec; 5(6):511-5. PubMed ID: 1791611 [TBL] [Abstract][Full Text] [Related]
23. Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension. Napoli C; Bruzzese G; Ignarro LJ; Crimi E; de Nigris F; Williams-Ignarro S; Libardi S; Sommese L; Fiorito C; Mancini FP; Cacciatore F; Liguori A Am Heart J; 2008 Dec; 156(6):1154.e1-8. PubMed ID: 19033012 [TBL] [Abstract][Full Text] [Related]
24. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril. Karlberg BE; Sjöstrand A; Ohman KP J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182 [TBL] [Abstract][Full Text] [Related]
25. Lack of cross sensitivity between captopril and enalapril. Jackson B; Maher D; Matthews PG; McGrath BP; Johnston CI Aust N Z J Med; 1988 Feb; 18(1):21-7. PubMed ID: 2840055 [TBL] [Abstract][Full Text] [Related]
26. [Comparison of the efficacy of enalapril + hydrochlorothiazide and captopril + hydrochlorothiazide combinations in mild-to-moderate arterial hypertension by ambulatory measurement of blood pressure]. Mayaudon H; Chanudet X; Janin G; Madonna O Ann Cardiol Angeiol (Paris); 1995 May; 44(5):235-41. PubMed ID: 7639505 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin-converting enzyme inhibitors in hypertension: a review. Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182 [TBL] [Abstract][Full Text] [Related]
36. Side effects and metabolic effects of converting enzyme inhibitors. Omae T; Kawano Y; Yoshida K Clin Exp Hypertens A; 1987; 9(2-3):635-42. PubMed ID: 3038427 [TBL] [Abstract][Full Text] [Related]
37. [The antagonistic effect of aspirin on the expression of prostaglandin participation in the antihypertensive activity of ACE inhibitors]. Alimento M; Campodonico J; Santambrogio G; Rossi M; Trabattoni D; Celeste F; Guazzi M Cardiologia; 1997 Jun; 42(6):605-10. PubMed ID: 9289376 [TBL] [Abstract][Full Text] [Related]
38. Long-term renal effects of enalapril therapy in patients with renal insufficiency. Smith RD; Rodel PV; Mulcahy WS; Price BA Nephron; 1990; 55 Suppl 1():49-58. PubMed ID: 2189074 [TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review. Kubo SH; Cody RJ Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938 [TBL] [Abstract][Full Text] [Related]
40. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor. Giles TD; Fisher MB; Rush JE Am J Med; 1988 Sep; 85(3B):44-7. PubMed ID: 2844087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]